2021
DOI: 10.18203/2320-6012.ijrms20215061
|View full text |Cite
|
Sign up to set email alerts
|

Treatment with clobetasol propionate 0.025% topical therapy in various dermatoses

Abstract: Owing to their anti-inflammatory and vasoconstrictive properties. Topical corticosteroids (TCs) provide benefits in various dermatological conditions, including atopic eczema, psoriasis, chronic hand eczema, and localized vitiligo. Clobetasol propionate (CP) is the most common topical agent possessing anti-inflammatory, antimitotic, antipruritic, and immunosuppressive properties that are employed in the management of plaque psoriasis. CP 0.025% cream was approved by the United States food and drug administrati… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Publication Types

Select...

Relationship

0
0

Authors

Journals

citations
Cited by 0 publications
references
References 4 publications
(6 reference statements)
0
0
0
Order By: Relevance

No citations

Set email alert for when this publication receives citations?